Latest News
News from the FDA/CDC
FDA labeling templates smooth way for OTC naloxone
The templates aim to ease the submission process for manufacturers.
Literature Review
Frailty may affect the expression of dementia
People with higher degrees of frailty may be more likely to have more Alzheimer’s disease pathology and clinical dementia.
Feature
GoFundMe CEO: ‘Gigantic gaps’ in health system showing up in crowdfunding
Scrolling through GoFundMe reveals seemingly an endless number of people who need help or support. A common theme: the cost of health care.
Conference Coverage
Obesity paradox applies to post-stroke mortality
News
FDA approves generic version of vigabatrin
Prior to approval, vigabatrin had been included on an FDA list of off-patent, off-exclusivity branded drugs without approved generics.
Literature Review
DMTs, stem cell transplants both reduce disease progression in MS
Literature Review
Active migraine in women linked to lower risk of developing T2DM
There was a linear decrease in prevalence of migraine leading up to T2DM diagnosis among those who were eventually diagnosed with it.
Literature Review
Neurologic Disease Eventually Affects Half of Women and One-Third of Men
Around one-half of women and one-third of men will develop dementia, stroke, or parkinsonism during their lifetime,...
Literature Review
Virus-Specific T-Cell Infusions May Resolve Progressive Multifocal Leukoencephalopathy
Infusion of allogeneic BK virus-specific T cells may be an effective treatment for patients with progressive multifocal...
News
Dr. Bernard Maria Recognized With Prestigious Child Neurology Honor
Bernard Maria, MD, MBA, Director of the Division of Child Neurology and Developmental Medicine at Goryeb Children’s Hospital in Morristown, NJ,...
Latest News
FDA Approves Galcanezumab for Migraine Prevention
ROCKVILLE, MD—The FDA has approved galcanezumab-gnlm (Emgality) for the preventive treatment of migraine in adults. Eli...